Literature DB >> 32507946

Validation of the Oxford Knee Score and Lower Extremity Functional Score questionnaires for use in Slovenia.

Armin H Paravlic1, Sasa Pisot2, Petar Mitic3, Rado Pisot2.   

Abstract

BACKGROUND: With the increasing prevalence of total knee replacement (TKR) due to knee osteoarthritis, the absence of patient-reported outcome measures in Slovenia must be addressed. QUESTIONS/PURPOSES: (1) We cross-culturally adapted Oxford Knee Score (OKS) and Lower Extremity Functional Scale (LEFS) questionnaires to the Slovenian-speaking community. (2) We evaluated OKS and LEFS psychometric characteristics. PATIENTS AND METHODS: In the first assessment (Time 1) Slovenian versions of both questionnaires (OKS-Slo and LEFS-Slo), knee pain, timed-up to go (TUG) and sit to stand (STS) tests were completed by 123 subjects (55% females), of which 78 were patients scheduled for TKR and 45 were healthy age-matched controls. The questionnaires were assessed one week apart (Time 2) to investigate the test-retest reliability, with 121 subjects (98.4%) completing second measurements.
RESULTS: Significant differences were observed between the two groups. Where patients had greater body mass index, they were slower in TUG, weaker in STS, had greater knee pain in both knees and scored lower on both questionnaires. Additionally, correlation analysis showed that OKS-Slo and LEFS-Slo correlated almost perfectly (correlation coefficient [CC] = .968, p < 0.001). Excellent negative correlations were observed with TUG (OKS-Slo/CC = - 0.679, p < 0.001; LEFS-Slo/CC = - 0.692, p < 0.001) and STS (OKS-Slo/CC = 0.790, p < 0.001; LEFS-Slo/CC = 0.815, p < 0.001) tests, while knee pain of affected leg correlated the most (OKS-Slo/CC = - 0.923, p < 0.001; LEFS-Slo/CC = - 0.915, p < 0.001). The Cronbach's alpha coefficient for both the OKS-Slo and LEFS-Slo ranged between 0.87 and 0.99, while the interclass correlation coefficient was excellent; i.e., 0.99. Finally, both questionnaires proved to be unidimensional measures.
CONCLUSION: The Slovenian version of both questionnaires is feasible, valid and reliable for use in clinical studies including the older adult population in Slovenia. LEVEL OF EVIDENCE: Level III, Diagnostic-case-control study.

Entities:  

Keywords:  Osteoarthritis; Physical function; Psychometric properties; Quality of life; Self-reported measures

Mesh:

Year:  2020        PMID: 32507946     DOI: 10.1007/s00402-020-03498-0

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  3 in total

1.  The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network.

Authors:  J M Binkley; P W Stratford; S A Lott; D L Riddle
Journal:  Phys Ther       Date:  1999-04

2.  Oxford Knee Score: cross-cultural adaptation and validation of the Turkish version in patients with osteoarthritis of the knee.

Authors:  Baki Umut Tuğay; Nazan Tuğay; Hande Güney; Gizem İrem Kınıklı; İnci Yüksel; Bülent Atilla
Journal:  Acta Orthop Traumatol Turc       Date:  2016       Impact factor: 1.511

Review 3.  Burden of major musculoskeletal conditions.

Authors:  Anthony D Woolf; Bruce Pfleger
Journal:  Bull World Health Organ       Date:  2003-11-14       Impact factor: 9.408

  3 in total
  2 in total

1.  Traditional Chinese-Hong Kong version of Forgotten Joint Score-12 (FJS-12) for patients with osteoarthritis of the knee underwent joint replacement surgery: cross-cultural and sub-cultural adaptation, and validation.

Authors:  Kevin Ki-Wai Ho; Wai-Wang Chau; Lawrence Chun-Man Lau; Michael Tim-Yun Ong
Journal:  BMC Musculoskelet Disord       Date:  2022-03-08       Impact factor: 2.362

Review 2.  Systematic Review of Patient-Reported Outcome Measures for Patients with Exercise-Induced Leg Pain.

Authors:  Alejandro Castillo-Domínguez; Jerónimo C García-Romero; José Ramón Alvero-Cruz; Tomás Ponce-García; Javier Benítez-Porres; Joaquín Páez-Moguer
Journal:  Medicina (Kaunas)       Date:  2022-06-23       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.